1,705
Trials as lead sponsor
Most active programmes
The drugs appearing most often across Takeda's recently active trials. Comparator arms are excluded.
- Zasocitinib9 trials
- Vedolizumab IV5 trials
- Mezagitamab5 trials
- Vedolizumab5 trials
- TAK-3604 trials
- Vedolizumab SC3 trials
Upcoming readouts
Next primary completion dates among Takeda's active phase 2 and phase 3 trials. Dates are registry estimates and move often, which is exactly what the tracker watches.
- Sept 2026A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Particip…Phase 2
- Oct 2026A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyPhase 3
- Nov 2026A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)Phase 2
- Nov 2026A Study of TAK-360 in Adults With Idiopathic HypersomniaPhase 2
- Jan 2027A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Mar…Phase 3
- Feb 2027A Study of Teduglutide in Chinese Adults With Short Bowel SyndromePhase 3
Top therapeutic areas
Conditions studied most often across Takeda's recently active trials.
- Crohn's Disease15 trials
- Ulcerative Colitis12 trials
- Hereditary Angioedema (HAE)6 trials
- Narcolepsy Type 14 trials
- Dengue Fever3 trials
- Multiple Myeloma3 trials
Takeda trials
The 50 most significant of Takeda's recently active trials, soonest estimated readout first.
Select any row for the full record; the change timeline unlocks with tracking.
| Trial | Phase | Stability | Status | Enrollment | Est. readout |
|---|---|---|---|---|---|
| A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in ArgentinaNCT06213974 | — | Not yet scored | OngoingRecruiting | 10 est. | 31 Jul 2026 |
| HYPNOSEpidemiology of Narcolepsy Type 1 and Type 2 in SpainNCT07299097 | — | Not yet scored | OngoingRecruiting | 100 est. | 31 Jul 2026 |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseNCT06233461TAK-279 | Phase 2 | Locked · track to reveal | OngoingRecruiting | 268 est. | 18 Sept 2026 |
| A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South KoreaNCT06550882OBIZUR | — | Not yet scored | OngoingRecruiting | 9 est. | 30 Sept 2026 |
| Gaucher Disease Outcome Survey (GOS)NCT03291223 | — | Not yet scored | OngoingRecruiting | 1,257 est. | 30 Sept 2026 |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisNCT06254950TAK-279 | Phase 2 | Locked · track to reveal | OngoingActive, not recruiting | 207 est. | 30 Sept 2026 |
| A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access ProgramNCT07429942 | — | Not yet scored | OngoingNot yet recruiting | 94 est. | 30 Sept 2026 |
| A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyNCT07363720TAK-861 | Phase 3 | Locked · track to reveal | OngoingRecruiting | 88 est. | 2 Oct 2026 |
| A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi ArabiaNCT07263685 | — | Not yet scored | OngoingRecruiting | 50 est. | 30 Oct 2026 |
| A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)NCT06952699TAK-360 | Phase 2 | Locked · track to reveal | OngoingRecruiting | 88 est. | 30 Nov 2026 |
| A Study of TAK-360 in Adults With Idiopathic HypersomniaNCT06812078TAK-360 | Phase 2 | Locked · track to reveal | OngoingRecruiting | 96 est. | 30 Nov 2026 |
| A Study on Infections in Adults With Ulcerative Colitis/Crohn's DiseaseNCT07250815 | — | Not yet scored | OngoingNot yet recruiting | 23,900 est. | 15 Dec 2026 |
| BV-MAZOVIAA Study of Brentuximab Vedotin in Adults With Hodgkin's LymphomaNCT05100056 | — | Not yet scored | OngoingRecruiting | 70 est. | 13 Jan 2027 |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)NCT05319353Maribavir | Phase 3 | Locked · track to reveal | OngoingRecruiting | 80 est. | 18 Jan 2027 |
| A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeNCT06973304Teduglutide | Phase 3 | Locked · track to reveal | OngoingRecruiting | 13 est. | 10 Feb 2027 |
| PRIME-QA Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in MalaysiaNCT06388785 | — | Not yet scored | OngoingActive, not recruiting | 2,000 est. | 8 May 2027 |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesNCT06671483Zasocitinib | Phase 3 | Locked · track to reveal | OngoingRecruiting | 1,088 est. | 18 May 2027 |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesNCT06671496Zasocitinib | Phase 3 | Locked · track to reveal | OngoingRecruiting | 600 est. | 18 May 2027 |
| VICTRIVAA Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseNCT06227910Vedolizumab | Phase 3 | Locked · track to reveal | OngoingRecruiting | 396 est. | 8 Jun 2027 |
| AHAEA Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary AngioedemaNCT07293364Technochrom C1-INH Kit | Na | Locked · track to reveal | OngoingRecruiting | 514 est. | 12 Jun 2027 |
| LEADERA Study of Real Life Treatment for Multiple Myeloma (MM)NCT04985643 | — | Not yet scored | OngoingActive, not recruiting | 357 est. | 20 Jun 2027 |
| A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseNCT06045754Vedolizumab | Phase 4 | Locked · track to reveal | OngoingRecruiting | 100 est. | 28 Jun 2027 |
| A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)NCT06095128Vedolizumab | Phase 4 | Locked · track to reveal | OngoingRecruiting | 65 est. | 9 Jul 2027 |
| A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)NCT04779320Vedolizumab IV | Phase 3 | Locked · track to reveal | OngoingRecruiting | 120 est. | 13 Sept 2027 |
| Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative ColitisNCT03221036Vedolizumab IV | Phase 3 | Locked · track to reveal | OngoingActive, not recruiting | 392 est. | 24 Sept 2027 |
| PANORAMAA Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community SettingNCT06581328Vedolizumab IV | Phase 4 | Locked · track to reveal | OngoingRecruiting | 400 est. | 1 Oct 2027 |
| A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerNCT06562543Fruquintinib | Phase 4 | Locked · track to reveal | OngoingRecruiting | 78 est. | 4 Oct 2027 |
| A Study of Zasocitinib in Adults With Nonsegmental VitiligoNCT07108283Zasocitinib | Phase 2 | Locked · track to reveal | OngoingRecruiting | 200 est. | 12 Oct 2027 |
| A Study of Rusfertide in Japanese Adults With Polycythemia VeraNCT07648030Rusfertide | Phase 2 | Not yet scored | OngoingNot yet recruiting | 9 est. | 28 Oct 2027 |
| A Study of Prucalopride in Breastfeeding Women With ConstipationNCT04838522 | — | Not yet scored | OngoingRecruiting | 12 est. | 31 Oct 2027 |
| A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years OldNCT02616302Dexlansoprazole | Phase 2 | Locked · track to reveal | OngoingActive, not recruiting | 71 est. | 31 Oct 2027 |
| A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's DiseaseNCT06100289Vedolizumab IV | Phase 3 | Locked · track to reveal | OngoingRecruiting | 70 est. | 15 Nov 2027 |
| A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)NCT07633301TAK-360 | Phase 2 | Not yet scored | OngoingRecruiting | 92 est. | 28 Nov 2027 |
| EXPLORHAEA Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in EgyptNCT07218393 | — | Not yet scored | OngoingNot yet recruiting | 100 est. | 1 Dec 2027 |
| A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaNCT06722235Mezagitamab | Phase 3 | Locked · track to reveal | OngoingRecruiting | 171 est. | 16 Mar 2028 |
| A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's DiseaseNCT07403968Zasocitinib | Phase 2 | Locked · track to reveal | OngoingNot yet recruiting | 20 est. | 30 Mar 2028 |
| A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in PolandNCT07623174 | — | Not yet scored | OngoingNot yet recruiting | 110 est. | 31 Mar 2028 |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsNCT06499285Elritercept | Phase 3 | Locked · track to reveal | OngoingRecruiting | 225 est. | 1 May 2028 |
| A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic SyndromesNCT07319845TAK-226 | Phase 2 | Locked · track to reveal | OngoingRecruiting | 42 est. | 26 Jun 2028 |
| A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent SurgeryNCT05156983TAK-330 | Phase 3 | Locked · track to reveal | OngoingRecruiting | 440 est. | 30 Aug 2028 |
| A Study of Mezagitamab in Adults With Kidney Condition Called IgA NephropathyNCT06963827Mezagitamab | Phase 3 | Locked · track to reveal | OngoingRecruiting | 347 est. | 7 Sept 2028 |
| A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaNCT06980480IGI, 10% | Phase 3 | Locked · track to reveal | OngoingRecruiting | 183 est. | 11 Sept 2028 |
| MarsLight-11A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung CancerNCT07217301TAK-928 | Phase 3 | Locked · track to reveal | OngoingRecruiting | 600 est. | 1 Nov 2028 |
| A Study of TAK-188 in Adults With Advanced or Spreading Solid TumorsNCT07205718TAK-188 | Phase 1 | Locked · track to reveal | OngoingRecruiting | 223 est. | 26 Dec 2028 |
| A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantNCT07613359Mezagitamab | Phase 2 | Locked · track to reveal | OngoingNot yet recruiting | 36 est. | 15 Jan 2029 |
| Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin ProteinNCT05677971Fazirsiran Injection | Phase 3 | Locked · track to reveal | OngoingRecruiting | 160 est. | 17 Jan 2029 |
| ELRiSE MDSA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsNCT07422480Elritercept | Phase 3 | Locked · track to reveal | OngoingRecruiting | 300 est. | 30 Apr 2029 |
| A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaNCT06948318Mezagitamab | Phase 3 | Locked · track to reveal | OngoingRecruiting | 150 est. | 29 Jul 2029 |
| A Study of TAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisNCT06550076TAK-279 | Phase 3 | Locked · track to reveal | OngoingActive, not recruiting | 2,099 est. | 5 Aug 2029 |
| A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive DisorderNCT07204314Vortioxetine tablets | Phase 3 | Locked · track to reveal | OngoingRecruiting | 180 est. | 30 Sept 2029 |